C40B 30 - Methods of screening libraries

Patents for C40B 30 - Methods of screening libraries (11,320)
10/2011
10/27/2011	US20110262350 Breast endothelial cell expression patterns
10/27/2011	US20110262025 Cosmetic Compositions and Methods for Maintaining and Improving Barrier Function of the Stratum Corneum and to Reduce the Visible Signs of Aging in Skin
10/27/2011	CA2774618A1 Methods and devices for assessing infertility and/or egg quality
10/26/2011	EP2380661A2 Modified support materials for catalysts
10/20/2011	WO2011130726A2 Ligands for odor receptors and olfactory neurons
10/20/2011	WO2011130152A2 Method for identifying hla complexes associated with adverse drug reactions
10/20/2011	WO2011127561A1 Methods and compositions for diagnosing pulmonary fibrosis subtypes and assessing the risk of primary graft dysfunction after lung transplantation
10/20/2011	US20110258733 Soybean plants having superior agronomic performance and methods for their production
10/20/2011	US20110257098 Compositions and methods for treating growth hormone deficiency
10/20/2011	US20110257036 Methods and Compositions for the Diagnosis of Cancer Susceptibilities and Defective DNA Repair Mechanisms and Treatment Thereof
10/20/2011	US20110257035 Identification of signature genes associated with hepatocellular carcinoma
10/20/2011	US20110257034 Methods for identifying genes which predict disease outcome for patients with colon cancer
10/20/2011	US20110257033 Polymer-nanostructure composition for selective molecular recognition
10/20/2011	US20110257032 Modular glycan arrays
10/20/2011	US20110257031 Nucleic acid, biomolecule and polymer identifier codes
10/20/2011	US20110257030 Biomarker-Based Methods For Formulating Compositions That Improve Skin Quality And Reduce The Visible Signs Of Aging In Skin For Individuals In A Selected Population
10/20/2011	US20110257029 Biomarkers for pancreatic cancer and diagnostic methods
10/20/2011	US20110257028 Method for selectively binding a substrate to sorbents by way of at least bivalent bonds
10/20/2011	US20110257027 Gamma-secretase substrate and methods of use
10/20/2011	US20110257026 Dna intercalator detection
10/20/2011	US20110257025 Method for tumor classification
10/20/2011	US20110257024 Application of surface plasmon resonance technology for detecting and genotyping hpv
10/20/2011	US20110257023 Methods, systems, and software for identifying functional biomolecules
10/20/2011	US20110257022 Method for assessment of severity of liver cirrhosis
10/20/2011	US20110257021 Use of the mst protein for the treatment of a thromboembolic disorder
10/20/2011	US20110257020 Biomarker-Based Methods For Formulating Compositions That Improve Skin Quality And Reduce The Visible Signs Of Aging In Skin
10/20/2011	US20110256169 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
10/20/2011	US20110256121 Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases
10/20/2011	US20110256090 Method for Identifying Genes Involved in Trail-Induced Apoptosis and Therapeutic Applications Thereof
10/20/2011	DE102011101888A1 Screening method comprises making ceramic or glass plates with artificial contamination level or degree of soiling, providing mixture of purified water, carbon dioxide, a blowing agent and optionally alcohol and discovering cleaning effect
10/20/2011	CA2796217A1 Biomarkers based on a multi-cancer invasion-associated mechanism
10/20/2011	CA2795901A1 Methods and compositions for diagnosing pulmonary fibrosis subtypes and assessing the risk of primary graft dysfunction after lung transplantation
10/19/2011	EP2376920A1 Methods of detection of changes in cells
10/19/2011	EP1383793B1 Insulin and igf-1 receptor agonists and antagonists
10/19/2011	CN102219853A Anti-H5N1 type bird flue virus vicuna VHH heavy chain antibody as well as preparation method and application thereof
10/13/2011	WO2011127194A1 Compositions and methods for identifying autism spectrum disorders
10/13/2011	WO2011127150A2 Gene-expression profiling with reduced numbers of transcript measurements
10/13/2011	WO2011125833A1 Constitution of tool for analyzing biomolecular interaction and analysis method using same
10/13/2011	US20110252490 Methods and Compositions for Increased Alpha-Prime Beta-Conglycinin Soybeans
10/13/2011	US20110251236 Galactokinase inhibitors
10/13/2011	US20110251135 Inhibitors of peritoneal seeding of cancer cells
10/13/2011	US20110251104 Compositions and methods for detecting deacetylase activity
10/13/2011	US20110251103 Targeted chemical high-throughput screening method
10/13/2011	US20110251102 High throughput screening of ion channels
10/13/2011	US20110251101 Combinatorial decoding of random nucleic acid arrays
10/13/2011	US20110251100 Compositions and methods for diagnosing and treating inflammatory bowel disease and related disorders
10/13/2011	US20110251099 SERUM MARKERS PREDICTING CLINICAL RESPONSE TO ANTI-TNFa ANTIBODIES IN PATIENTS WITH ANKYLOSING SPONDYLITIS
10/13/2011	US20110251098 Biomarkers in Peripheral Blood Mononuclear Cells for Diagnosing or Detecting Lung Cancers
10/13/2011	US20110251097 Diagnostic kit of colon cancer using colon cancer related marker and diagnostic method thereof
10/13/2011	US20110251096 Health Test for a Broad Spectrum of Health Problems
10/13/2011	US20110251095 Mara family helix-turn-helix domains and their methods of use
10/13/2011	US20110251094 Biomarkers for hypertensive disorders of pregnancy
10/13/2011	US20110251093 Analysis, secure access to, and transmission of array images
10/13/2011	US20110251092 Use of Photopolymerization for Amplification and Detection of a Molecular Recognition Event
10/13/2011	US20110251091 Thyroid tumors identified
10/13/2011	US20110251090 Pancreatic cancer related gene ttll4
10/13/2011	US20110251089 Methods for synthesis of encoded libraries
10/13/2011	US20110251088 lariat aptamer: aptamer candidate exclusion by nuclease digestion
10/13/2011	US20110251087 Prognostic and diagnostic method for cancer therapy
10/13/2011	US20110251086 Neuroblastoma prognostic multigene expression signature
10/13/2011	US20110251085 In vitro method to determine whether a drug candidate active against a target protein is active against a variant of said protein
10/13/2011	US20110251084 System for the Detection of a Biological Pathogen and Use Thereof
10/13/2011	US20110251083 Multiplexed Amplification of Short Nucleic Acids
10/13/2011	US20110251082 Biomarkers for breast cancer
10/13/2011	US20110251081 Methods and compositions for determining gene function
10/13/2011	US20110251080 Sample processing apparatus and method
10/13/2011	US20110251079 High throughput nucleic acid sequencing by expansion
10/13/2011	US20110251078 Methods for Sequencing Individual Nucleic Acids Under Tension
10/13/2011	US20110251077 Methods and Systems for Diagnosis of Non-Central Nervous System (CNS) Diseases in CNS Samples
10/13/2011	US20110251076 Non-invasive detection of fetal genetic traits
10/13/2011	US20110251075 System and method for the analysis of bodily fluids
10/13/2011	US20110250218 Disease-Associated Antigens and Methods of Use Thereof
10/13/2011	US20110250214 Drug delivery system toward demyelinating lesion and biochemical marker of demyelinating lesion
10/13/2011	US20110250179 Methods for treatment and diagnosis of cancer
10/13/2011	US20110250135 Piperazine Derivatives for Binding and Imaging Amyloid Plaques and Their Use
10/13/2011	CA2795776A1 Circulating biomarkers for disease
10/13/2011	CA2794709A1 Selection and use of host cells for production of glycoproteins
10/13/2011	CA2794522A1 Spatially encoded biological assays
10/11/2011	US8036831 Ligand searching device, ligand searching method, program, and recording medium
10/11/2011	US8034571 Microbial polynucleotides expressed during infection of a host
10/11/2011	US8034304 Process vessel with integral evaporator
10/06/2011	WO2011123857A1 Generation of antibodies to an epitope of interest
10/06/2011	WO2011066430A3 Therapeutic agents for neurodegenerative diseases
10/06/2011	US20110245322 Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of cf-associated mutant cystic fibrosis transmembrane conductance regulator
10/06/2011	US20110245279 Predictive marker for egfr inhibitor treatment
10/06/2011	US20110245153 Neutralizing Agents for Bacterial Toxins
10/06/2011	US20110245106 Sample Carrier and Method for Achieving Comparable Analytical Results By Aligning Test Substances on a Uniform Plane
10/06/2011	US20110245105 Methods and Kits for Direct Detection and Susceptibility Profiling of Beta-Lactam Resistant Bacteria
10/06/2011	US20110245104 Method for screening the sensitizing properties of chemical compounds
10/06/2011	US20110245103 Predicting response to a her inhibitor
10/06/2011	US20110245102 Gene Expression Profiling of EGFR Positive Cancer
10/06/2011	US20110245101 Co-localization affinity assays
10/06/2011	US20110245100 Generation of antibodies to an epitope of interest
10/06/2011	US20110245099 Compositions And Methods For Immunodominant Antigens of Mycobacterium Tuberculosis
10/06/2011	US20110245098 Polymeric carriers for immunohistochemistry and in situ hybridization
10/06/2011	US20110245097 Methods and systems for extending dynamic range in assays for the detection of molecules or particles
10/06/2011	US20110245096 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110245095 Fast assignment of adequate chemotherapy with latinum based drugs for cancer patients based on the identification of constitutional brcal mutations
10/06/2011	US20110245094 Detection of microbial nucleic acids
10/06/2011	US20110245093 Functional protein arrays

1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 114